QGE031
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for QGE031, covering 2012-07-23 to 2020-08-14. Get the full timeline:
Most recent: Clinical Trial Update: A Safety Extension Study to Evaluate the Long-term Safety of QGE031 in Chronic Spontaneous Urticaria (CSU) Patients [Phase 2]